Rasool Haddadi

16.0k total citations
52 papers, 654 citations indexed

About

Rasool Haddadi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Rasool Haddadi has authored 52 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 10 papers in Neurology. Recurrent topics in Rasool Haddadi's work include Neuroscience and Neuropharmacology Research (10 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Alzheimer's disease research and treatments (5 papers). Rasool Haddadi is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Alzheimer's disease research and treatments (5 papers). Rasool Haddadi collaborates with scholars based in Iran, United States and United Kingdom. Rasool Haddadi's co-authors include Alireza Mohajjel Nayebi, Alireza Komaki‬, Alireza Nourian, Akram Ranjbar, Masoumeh Jorjani, Mohammadmahdi Sabahi, Mojdeh Mohammadi, Safar Farajnia, Sara Soleimani Asl and Manoochehr Karami and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and European Journal of Pharmacology.

In The Last Decade

Rasool Haddadi

49 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rasool Haddadi Iran 16 174 132 108 95 87 52 654
Tae Ju Park South Korea 14 195 1.1× 74 0.6× 158 1.5× 70 0.7× 60 0.7× 29 592
Alireza Mohajjel Nayebi Iran 19 231 1.3× 115 0.9× 210 1.9× 222 2.3× 137 1.6× 59 989
Ming Xue China 16 435 2.5× 90 0.7× 70 0.6× 47 0.5× 99 1.1× 74 1.0k
Eman N. Hosny Egypt 12 90 0.5× 77 0.6× 58 0.5× 60 0.6× 46 0.5× 27 484
Zhipeng Teng China 12 260 1.5× 86 0.7× 164 1.5× 51 0.5× 105 1.2× 19 755
Anna Ciampa Italy 13 204 1.2× 73 0.6× 79 0.7× 48 0.5× 69 0.8× 13 928
Robson da Costa Brazil 19 211 1.2× 102 0.8× 281 2.6× 94 1.0× 42 0.5× 29 927
Mariano Catanesi Italy 17 374 2.1× 58 0.4× 200 1.9× 106 1.1× 95 1.1× 25 931
B. Mahalakshmi Taiwan 17 331 1.9× 44 0.3× 184 1.7× 62 0.7× 51 0.6× 34 833
Giuseppina Frasca Italy 17 267 1.5× 93 0.7× 130 1.2× 67 0.7× 39 0.4× 32 738

Countries citing papers authored by Rasool Haddadi

Since Specialization
Citations

This map shows the geographic impact of Rasool Haddadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rasool Haddadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rasool Haddadi more than expected).

Fields of papers citing papers by Rasool Haddadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rasool Haddadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rasool Haddadi. The network helps show where Rasool Haddadi may publish in the future.

Co-authorship network of co-authors of Rasool Haddadi

This figure shows the co-authorship network connecting the top 25 collaborators of Rasool Haddadi. A scholar is included among the top collaborators of Rasool Haddadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rasool Haddadi. Rasool Haddadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alavinia, Sedigheh, et al.. (2025). Improving the effectiveness of anticancer properties of capecitabine using aminocaproic acid-hyaluronic acid/sulfonamide IR-MOF nanoplatform for colon cancer treatment. Carbohydrate Polymer Technologies and Applications. 10. 100827–100827. 3 indexed citations
2.
Haddadi, Rasool, et al.. (2024). Development of a hydrogel containing bisabolol-loaded nanocapsules for the treatment of atopic dermatitis in a Balb/c mice model. International Journal of Pharmaceutics. 656. 124029–124029. 11 indexed citations
3.
Mohammadi, Mojdeh, et al.. (2024). The role of histamine H1 receptor in the anterior cingulate cortex on nociception level following acute restraint stress in male rats. Pharmacology Research & Perspectives. 12(2). e1188–e1188. 1 indexed citations
5.
Asl, Sara Soleimani, et al.. (2023). Preparation of polyvinyl alcohol hydrogel containing chlorogenic acid microspheres and its evaluation for use in skin wound healing. Journal of Biomaterials Applications. 37(9). 1667–1675. 12 indexed citations
6.
Sabahi, Mohammadmahdi, et al.. (2023). Silibinin chronic treatment in a rat model of Parkinson disease: A comprehensive in-vivo evaluation and in silico molecular modeling. European Journal of Pharmacology. 941. 175517–175517. 7 indexed citations
7.
Haddadi, Rasool, et al.. (2023). Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article. Frontiers in Neuroscience. 17. 1188839–1188839. 24 indexed citations
8.
Arabi, Amir, Seyed Asaad Karimi, Iraj Salehi, Rasool Haddadi, & Alireza Komaki‬. (2023). Effects of sesamin on Aβ1-42-induced oxidative stress and LTP impairment in a rat model of Alzheimer's disease. Metabolic Brain Disease. 38(5). 1503–1511. 11 indexed citations
9.
Ranjbar, Akram, et al.. (2023). Cardioprotective effect of vitamin D3 on cisplatin-induced cardiotoxicity in male mice: role of oxidative stress. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(7). 4761–4769. 1 indexed citations
10.
Vahdatinia, Farshid, et al.. (2023). 3D-Printed Soft Membrane for Periodontal Guided Tissue Regeneration. Materials. 16(4). 1364–1364. 13 indexed citations
11.
Haddadi, Rasool, et al.. (2023). Peroxisome proliferator activated receptor-gamma (PPAR-γ) ligand, pioglitazone, increases analgesic and anti-inflammatory effects of naproxen. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(3). 1633–1646. 5 indexed citations
12.
Sabahi, Mohammadmahdi, et al.. (2022). Post treatment with Gastrodin suppresses oxidative stress and attenuates motor disorders following 6-OHDA induced Parkinson disease. Neuroscience Letters. 790. 136884–136884. 15 indexed citations
13.
Mohammadi, Younes, et al.. (2022). Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study. Pharmacological Reports. 74(6). 1296–1305. 5 indexed citations
15.
Haddadi, Rasool, et al.. (2020). Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms. Phytomedicine. 79. 153320–153320. 37 indexed citations
16.
Haddadi, Rasool, et al.. (2018). The Preventive/Protective Effect of Testosterone on Haloperidol-Induced Extrapyramidal Disorders in Male Rats. SHILAP Revista de lepidopterología. 4 indexed citations
17.
Sabahi, Mohammadmahdi, et al.. (2018). Effects of Estrogen and Progesterone on Catalepsy and Motor and Balance Impairment Classified as Haloperidol-induced Extrapyramidal Disorders. Journal of Obstetrics Gynecology and Cancer Research. 3(1). 1–7. 4 indexed citations
18.
Nayebi, Alireza Mohajjel, et al.. (2016). Effects of WR1065 on 6-hydroxydopamine-induced motor imbalance: Possible involvement of oxidative stress and inflammatory cytokines. Neuroscience Letters. 627. 7–12. 15 indexed citations
19.
Haddadi, Rasool, et al.. (2015). Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats. Advanced Pharmaceutical Bulletin. 5(4). 463–469. 18 indexed citations
20.
Nayebi, Alireza Mohajjel, et al.. (2014). Effect of Chronic Administration of Buspirone and Fluoxetine on Inflammatory Cytokines in 6-Hydroxydopamine-lesioned Rats. Drug Research. 65(8). 393–397. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026